Potenza Therapeutics Overview

  • Founded
  • 2014
Founded
  • Status
  • Acquired/​Merged
  • Employees
  • 19
Employees
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $165M
Latest Deal Amount

Potenza Therapeutics General Information

Description

Operator of a biotechnology company intended build a portfolio of oncology programs that utilize the body's own immune system to seek out, recognize and destroy tumors. The company's programs leverage novel biological insights into mechanisms by which cancer cells evade detection and destruction by the immune system, enabling medical practitioners to improve the health of patients through provision of innovative and reliable pharmaceuticals.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Parent Company
Primary Office
  • 1030 Massachusetts Avenue
  • Suite 210
  • Cambridge, MA 02138
  • United States
+1 (617) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Potenza Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 14-Dec-2018 $165M 000 00000 Completed Generating Revenue
3. Early Stage VC 29-Dec-2017 000 000 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 02-Mar-2016 $30M 0000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view Potenza Therapeutics’s complete valuation and funding history, request access »

Potenza Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A 00,000,000 00.000000 00.00 00 00 00 00 00.000
Series AS 00,000,000 00.000000 00.00 00 00 00 00 00.000
To view Potenza Therapeutics’s complete cap table history, request access »

Potenza Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Operator of a biotechnology company intended build a portfolio of oncology programs that utilize the body's own immune s
Biotechnology
Cambridge, MA
19 As of 2018
000
0000 0000-00-00
000000&0 000

00000000

mod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exerci
0000000000000
Gaithersburg, MD
00 As of 0000
000.00
000 0000-00-00
00000000000 000.00

00000000

laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptat
0000 000000000
Rockville, MD
0 As of 0000
000.00
0000000000 0 000.00
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Potenza Therapeutics Competitors (56)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
NexImmune Venture Capital-Backed Gaithersburg, MD 00 000.00 00000000000 000.00
000000000 00000000 Venture Capital-Backed Rockville, MD 0 000.00 0000000000 0 000.00
00000000 Venture Capital-Backed San Carlos, CA 00 00000 00000000000 00000
0000 000000 Formerly VC-backed Santa Monica, CA 000 00000 000000&0 00000
000000 00000000000 Formerly VC-backed South San Francisco, CA 000 00000 000000 - 000 00000
You’re viewing 5 of 56 competitors. Get the full list »

Potenza Therapeutics Executive Team (11)

Name Title Board Seat Contact Info
Reid Leonard Ph.D Chief Operating Officer
Cynthia Seidel-Dugan Ph.D Chief Scientific Officer
Ana Anderson Ph.D Scientific Co-Founder & Member of the Scientific Advisory Board
Charles Drake Ph.D Scientific Co-Founder & Member of the Scientific Advisory Board
Jedd Wolchok Ph.D Scientific Co-Founder & Member of the Scientific Advisory Board
You’re viewing 5 of 11 executive team members. Get the full list »

Potenza Therapeutics Board Members (5)

Name Representing Role Since
Arnold Oronsky Ph.D InterWest Partners Board Member 000 0000
Daniel Hicklin Ph.D Self Co-Founder, Chief Executive Officer, President & Board Member 000 0000
To view Potenza Therapeutics’s complete board members history, request access »

Potenza Therapeutics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Potenza Therapeutics Former Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Astellas Venture Management Corporate Venture Capital Minority 000 0000 000000 0
CRV Venture Capital Minority 000 0000 000000 0
InterWest Healthcare Partners Venture Capital Minority 000 0000 000000 0
Johns Hopkins Technology Ventures Accelerator/Incubator 000 0000 000000 0
MPM Capital Venture Capital Minority 000 0000 000000 0
To view Potenza Therapeutics’s complete investors history, request access »